illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Pharmaniaga Berhad
Company logo

Pharmaniaga Berhad | Sustainability Performance

https://www.pharmaniaga.com
Linkedin

Operates pharmaceutical manufacturing, distribution, and retail services in healthcare markets.

1994

Malaysia

1,001 - 5,000 employees

Pharmaceuticals

$500M - 1B in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2915
Overall
#9
in Malaysia
#65
in Pharmaceuticals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and exclusionsB-corp & CDP
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
IHH Healthcare

Malaysia, Hospital & Health Care, Hospital & Health Care


Company logo
Top Glove

Malaysia, Hospital & Health Care, Medical Device


Company logo
Industri Jamu Dan Farmasi Sido Muncul

Indonesia, Hospital & Health Care, Pharmaceuticals

Market cap

12.6B $, 2026▲75.2% YoY

Revenue

916.7M $, 2025▲4.3% YoY

R&D intensity

0.1% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

12.6B $, 2026▲75.2% YoY

Revenue

916.7M $, FY2025▲4.3% YoY

EBITDA

30.1M $, FY2025▼9.1% YoY

Operating margin

7% Industry: -24▲108.3% YoY

Revenue & EBITDA

$916.7MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

2.7M 2024▲242.3% YoY

Capex

7.2M 2024▼103.2% YoY

Debt/equity ratio

1.9 Industry: 0▼NaN% YoY

R&D intensity

0.1%FY2025

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Return on invested capital

4.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.8

▲ 6.7%

2023

0.9

▲ 7.2%

2024

0.9

▲ 1.3%

2025

4.3

2027

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Available

Workplace health & safety policy

Available

43%
Independent Directors

10 out of 23 incl. management

Powered by illuminem

Overall score

66

Environment

61

Social

99

Governance

39

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

CDP Scores


Climate Score

Not disclosed

Water Score

Not disclosed

A

A-

B

B-

C

C-

D

D-

Powered by illuminem and GIST impact

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


Total sustainability employees

7-10


    Available in
    Scale package

    Access
  • Email

  • Email